Malcolm Paterson is an Adjunct Professor in the Department of Biology with extensive experience in understanding the mechanisms of genotoxic stress and its impact on cell cycle control and DNA repair. His research focuses on the deregulation of human cellular processes that initiate cancer development, specifically looking at how environmental and hereditary interactions contribute to diseases like breast cancer. He has been involved in drug development projects, notably working with Herceptin (Trastuzumab) for breast cancer treatment. With degrees in Biology from Queen's University and Biomedical Sciences from the University of Tennessee, he combines his academic background with practical experiences in his research endeavors.